Last reviewed · How we verify
NCT05512117
Midline Catheters Versus Peripheral Catheters in Internal Medicine Unit
NA trial testing Midline insertion in Vascular Access Complication in 20 participants. Completed in 30 September 2017.
1 April 2017
Quick facts
| Lead sponsor | Hospital General Universitario de Valencia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 1 February 2017 |
| Primary completion | 1 April 2017 |
| Estimated completion | 30 September 2017 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Midline insertion
Conditions studied
- Vascular Access Complication — all drugs for Vascular Access Complication →
- Vascular Access Device Complications — all drugs for Vascular Access Device Complications →
Sponsor
Hospital General Universitario de Valencia
Who can join
Eligibility, any sex, with Vascular Access Complication or Vascular Access Device Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to evaluate the rate of complications and the duration of cannulation of a midline intravenous catheter compared to a short peripheral catheter in patients hospitalized in an Internal Medicine service of a Spanish hospital.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Usefulness of Midline Catheters versus Peripheral Venous Catheters in an Inpatient Unit: A Pilot Randomized Clinical Trial.
Villalba-Nicolau M, Chover-Sierra E, Saus-Ortega C, Ballestar-Tarín ML, et al · · 2022 · cited 7× · PMID 36412798 · DOI 10.3390/nursrep12040079
Verify or expand the search:
- PubMed search for NCT05512117
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vascular Access Complication
Currently open trials in the same condition.
- NCT07372027 — Single-Needle Distal Return for Long-Term Arteriovenous Fistula Care · NA · recruiting
- NCT07179536 — Time to Ambulation After ProGlide Closure · NA · recruiting
- NCT05490225 — Access Cannulation Trial II · NA · recruiting
- NCT06770374 — Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Ca · NA · recruiting
- NCT06566495 — Microorganisms on Reusable Tourniquets · active not recruiting
Other Hospital General Universitario de Valencia trials
Trials by the same sponsor.
- NCT05971095 — Comparison Between Percutaneous Femoral Nerve Neuromodulation Associated With Femoral Nerve Block and Standard Clinical · NA · unknown
- NCT05873894 — Acute Pain Oscillation in Electroencephalographic Monitoring Under General Anaesthesia · recruiting
- NCT04755478 — LUS to Assess Lung Injury After Lung Lobectomy · unknown
- NCT04581096 — Mapping COVID-19 Spread in a Tertiary Hospital · completed
- NCT04506515 — Psychological Impact of COVID-19 Pandemic in Healthcare Workers · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05512117 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital General Universitario de Valencia
- Last refreshed: 23 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05512117.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing